These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5460839)

  • 1. Renal effects of calcitonin.
    Cochran M; Peacock M; Sachs G; Nordin BE
    Br Med J; 1970 Jan; 1(5689):135-7. PubMed ID: 5460839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.
    Bijvoet OL; van der Sluys Veer J; Jansen AP
    Lancet; 1968 Apr; 1(7548):876-81. PubMed ID: 4171487
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C
    Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 9. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short term treatment of Paget's disease with porcine calcitonin].
    Renier JC; Boasson M; Jallet P; Bernat M
    Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):557-63. PubMed ID: 4797550
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoparathyroidism and Paget's disease: the effect of parathyroid hormone administration.
    Genuth SM; Klein L
    J Clin Endocrinol Metab; 1972 Nov; 35(5):693-9. PubMed ID: 4262771
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems concerning clinical application of calcitonin].
    Morii H
    Nihon Rinsho; 1972 Mar; 30(3):759-65. PubMed ID: 4556796
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of porcine calcitonin on hypercalcemia in man.
    Kammerman S; Canfield RE
    J Clin Endocrinol Metab; 1970 Jul; 31(1):70-5. PubMed ID: 4912878
    [No Abstract]   [Full Text] [Related]  

  • 17. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcitonin and calcium in the treatment of Paget's disease of bone (author's transl)].
    Rico Lenza H; Huertas García-Alejo R; Gómez Castresana F; Espinós Pérez D
    Med Clin (Barc); 1982 Mar 1-15; 78(5):179-82. PubMed ID: 7078307
    [No Abstract]   [Full Text] [Related]  

  • 19. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A; Valverde C; Tap G; Bazerque JJ; Ayrolles C
    Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience with a calcium-thiazide treatment for Paget's disease of bone.
    Evans RA; Dunstan CR; Wong SY; Hills E
    Miner Electrolyte Metab; 1982 Dec; 8(6):325-33. PubMed ID: 7167138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.